BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Spada A, Emami J, Tuszynski JA, Lavasanifar A. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery. Mol Pharm 2021;18:1862-94. [PMID: 33787270 DOI: 10.1021/acs.molpharmaceut.1c00046] [Cited by in Crossref: 45] [Cited by in F6Publishing: 59] [Article Influence: 45.0] [Reference Citation Analysis]
Number Citing Articles
1 Famta P, Shah S, Jain N, Srinivasarao DA, Murthy A, Ahmed T, Vambhurkar G, Shahrukh S, Singh SB, Srivastava S. Albumin-hitchhiking: Fostering the pharmacokinetics and anticancer therapeutics. Journal of Controlled Release 2023;353:166-185. [DOI: 10.1016/j.jconrel.2022.11.034] [Reference Citation Analysis]
2 Zhou Y, Yu S, Chen D, Li H, Xu P, Yuan C, Jiang L, Huang M. Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase–Human Serum Albumin Improves the Treatment Outcome of Triple-Negative Breast Cancer Therapy. Mol Pharmaceutics 2022. [DOI: 10.1021/acs.molpharmaceut.2c00297] [Reference Citation Analysis]
3 Diana EJ, Mathew TV. Synthesis and characterization of surface-modified ultrafine titanium dioxide nanoparticles with an antioxidant functionalized biopolymer as a therapeutic agent: Anticancer and antimicrobial evaluation. Colloids and Surfaces B: Biointerfaces 2022;220:112949. [DOI: 10.1016/j.colsurfb.2022.112949] [Reference Citation Analysis]
4 Nierenberg D, Flores O, Fox D, Sip YYL, Finn CM, Ghozlan H, Cox A, Coathup M, Mckinstry KK, Zhai L, Khaled AR. Macromolecules Absorbed from Influenza Infection-Based Sera Modulate the Cellular Uptake of Polymeric Nanoparticles. Biomimetics 2022;7:219. [DOI: 10.3390/biomimetics7040219] [Reference Citation Analysis]
5 Mardikasari SA, Budai-szűcs M, Orosz L, Burián K, Csóka I, Katona G. Development of Thermoresponsive-Gel-Matrix-Embedded Amoxicillin Trihydrate-Loaded Bovine Serum Albumin Nanoparticles for Local Intranasal Therapy. Gels 2022;8:750. [DOI: 10.3390/gels8110750] [Reference Citation Analysis]
6 Bańkosz M. Development of Chitosan/Gelatin-Based Hydrogels Incorporated with Albumin Particles. IJMS 2022;23:14136. [DOI: 10.3390/ijms232214136] [Reference Citation Analysis]
7 Patel A, Paul S, Akhtar N, Das S, Kar S, Bhattacharjee S, Manna D. Onium- and Alkyl Amine-Decorated Protein Nanoparticles as Antimicrobial Agents and Carriers of Antibiotics to Promote Synergistic Antibacterial and Antibiofilm Activities. ACS Appl Nano Mater 2022. [DOI: 10.1021/acsanm.2c03665] [Reference Citation Analysis]
8 Chapla R, Huynh KT, Schutt CE. Microbubble–Nanoparticle Complexes for Ultrasound-Enhanced Cargo Delivery. Pharmaceutics 2022;14:2396. [DOI: 10.3390/pharmaceutics14112396] [Reference Citation Analysis]
9 Tang S, Chen T, Zhang G, Zhang Z, Li Q, Liu M, Zhu Y, Li R, Tang X. Interaction of heptelidic acid with human serum albumin and colorectal cancer cells. Arabian Journal of Chemistry 2022. [DOI: 10.1016/j.arabjc.2022.104453] [Reference Citation Analysis]
10 Yang Z, Du Y, Lei L, Xia X, Wang X, Tong F, Li Y, Gao H. Co-delivery of ibrutinib and hydroxychloroquine by albumin nanoparticles for enhanced chemotherapy of glioma. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.122436] [Reference Citation Analysis]
11 Pandey V, Haider T, Agrawal P, Soni S, Soni V. Advances in Natural Polymeric Nanoparticles for the Drug Delivery. Advances in Drug Delivery Methods [Working Title] 2022. [DOI: 10.5772/intechopen.107513] [Reference Citation Analysis]
12 Paul M, Itoo AM, Ghosh B, Biswas S. Current trends in the use of human serum albumin for drug delivery in cancer. Expert Opin Drug Deliv 2022;:1-22. [PMID: 36253957 DOI: 10.1080/17425247.2022.2134341] [Reference Citation Analysis]
13 Chua A, Tran T, Pu S, Park J, Hadinoto K. Lyophilization of Curcumin–Albumin Nanoplex with Sucrose as Cryoprotectant: Aqueous Reconstitution, Dissolution, Kinetic Solubility, and Physicochemical Stability. IJMS 2022;23:11731. [DOI: 10.3390/ijms231911731] [Reference Citation Analysis]
14 Rout SK, Priya V, Vikas, Mehata AK, Muthu MS. Abciximab coated albumin nanoparticles of rutin for improved and targeted antithrombotic effect. Journal of Drug Delivery Science and Technology 2022;76:103785. [DOI: 10.1016/j.jddst.2022.103785] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Egil AC, Kesim H, Ustunkaya B, Kutlu Ö, Ozaydin Ince G. Self-assembled albumin nanoparticles for redox responsive release of curcumin. Journal of Drug Delivery Science and Technology 2022;76:103831. [DOI: 10.1016/j.jddst.2022.103831] [Reference Citation Analysis]
16 Kumbham S, Ghosh A, Ghosh B, Biswas S. Human serum albumin-poly(Lactide)-conjugated self-assembly NPs for targeted docetaxel delivery and improved therapeutic efficacy in oral cancer. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.09.250] [Reference Citation Analysis]
17 Meng R, Zhu H, Wang Z, Hao S, Wang B, Pugazhendhi ​. Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy. Journal of Nanomaterials 2022;2022:1-12. [DOI: 10.1155/2022/3052175] [Reference Citation Analysis]
18 Chen Y, Wang Z, Wang X, Su M, Xu F, Yang L, Jia L, Zhang Z. Advances in Antitumor Nano-Drug Delivery Systems of 10-Hydroxycamptothecin. Int J Nanomedicine 2022;17:4227-59. [PMID: 36134205 DOI: 10.2147/IJN.S377149] [Reference Citation Analysis]
19 Khosravifarsani M, Ait-mohand S, Paquette B, Sanche L, Guérin B. In vivo behavior of [64Cu]NOTA-terpyridine platinum, a novel chemo-radio-theranostic agent for imaging, and therapy of colorectal cancer. Front Med 2022;9. [DOI: 10.3389/fmed.2022.975213] [Reference Citation Analysis]
20 Siemiradzka W, Bułaś L, Dolińska B. Permeation of albumin through the skin depending on its concentration and the substrate used in simulated conditions in vivo. Biomed Pharmacother 2022;155:113722. [PMID: 36152412 DOI: 10.1016/j.biopha.2022.113722] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Yakimova L, Kunafina A, Mostovaya O, Padnya P, Mukhametzyanov T, Voloshina A, Petrov K, Boldyrev A, Stoikov I. Albumin/Thiacalix[4]arene Nanoparticles as Potential Therapeutic Systems: Role of the Macrocycle for Stabilization of Monomeric Protein and Self-Assembly with Ciprofloxacin. Int J Mol Sci 2022;23:10040. [PMID: 36077448 DOI: 10.3390/ijms231710040] [Reference Citation Analysis]
22 Kurtzhals P, Østergaard S, Nishimura E, Kjeldsen T. Derivatization with fatty acids in peptide and protein drug discovery. Nat Rev Drug Discov 2022. [PMID: 36002588 DOI: 10.1038/s41573-022-00529-w] [Reference Citation Analysis]
23 Takakura Y, Takahashi Y. Strategies for persistent retention of macromolecules and nanoparticles in the blood circulation. J Control Release 2022:S0168-3659(22)00543-0. [PMID: 36029894 DOI: 10.1016/j.jconrel.2022.05.063] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Mochizuki C, Nakamura J, Nakamura M. Preparation of Fetal Bovine Serum–Copper Phosphate Hybrid Particles under Cell Culture Conditions for Cancer Cell Treatment. ACS Omega. [DOI: 10.1021/acsomega.2c04096] [Reference Citation Analysis]
25 Zaragoza F. Non-Covalent Albumin Ligands in FDA-Approved Therapeutic Peptides and Proteins. J Med Chem 2022. [PMID: 35961011 DOI: 10.1021/acs.jmedchem.2c01021] [Reference Citation Analysis]
26 Aljabali AA, Rezigue M, Alsharedeh RH, Obeid MA, Mishra V, Serrano-Aroca Á, El-Tanani M, Tambuwala MM. Protein-based nanomaterials: a new tool for targeted drug delivery. Ther Deliv 2022. [PMID: 35924586 DOI: 10.4155/tde-2021-0091] [Reference Citation Analysis]
27 Alhaj-suliman SO, Wafa EI, Salem AK. Engineering nanosystems to overcome barriers to cancer diagnosis and treatment. Advanced Drug Delivery Reviews 2022. [DOI: 10.1016/j.addr.2022.114482] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Riccardi C, Piccolo M, Ferraro MG, Graziano R, Musumeci D, Trifuoggi M, Irace C, Montesarchio D. Bioengineered lipophilic Ru(III) complexes as potential anticancer agents. Biomaterials Advances 2022;139:213016. [DOI: 10.1016/j.bioadv.2022.213016] [Reference Citation Analysis]
29 Khalili L, Dehghan G, Sheibani N, Khataee A. Smart active-targeting of lipid-polymer hybrid nanoparticles for therapeutic applications: Recent advances and challenges. Int J Biol Macromol 2022;213:166-94. [PMID: 35644315 DOI: 10.1016/j.ijbiomac.2022.05.156] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Jiang M, Zhang Z, Li W, Man X, Sun H, Liang H, Yang F. Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer. J Med Chem 2022. [PMID: 35786921 DOI: 10.1021/acs.jmedchem.2c00698] [Reference Citation Analysis]
31 Lin X, Li N, Tang H. Recent Advances in Nanomaterials for Diagnosis, Treatments, and Neurorestoration in Ischemic Stroke. Front Cell Neurosci 2022;16:885190. [DOI: 10.3389/fncel.2022.885190] [Reference Citation Analysis]
32 Sinai Kunde S, Wairkar S. Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: Synthesis, optimisation and in vitro biological evaluation. Int J Pharm 2022;623:121926. [PMID: 35716974 DOI: 10.1016/j.ijpharm.2022.121926] [Reference Citation Analysis]
33 Wang W, Cai J, Wen J, Li X, Yu Y, Zhang L, Han Q, Wei Z, Ma Y, Ying F, Xu X, Li W, Yang Q, Sun S, He X, Cai L, Xiao H, Wang Z. Boosting ferroptosis via abplatin(iv) for treatment of platinum-resistant recurrent ovarian cancer. Nano Today 2022;44:101459. [DOI: 10.1016/j.nantod.2022.101459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Plumet C, Châtre R, Djago F, Péraudeau E, Blancart-Remaury Q, Clarhaut J, Geffroy C, Said Mohamed A, Opalinski I, Renoux B, Poinot P, Papot S. A β-Cyclodextrin-Albumin Conjugate for Enhancing Therapeutic Efficacy of Cytotoxic Drugs. Bioconjug Chem 2022. [PMID: 35613473 DOI: 10.1021/acs.bioconjchem.2c00182] [Reference Citation Analysis]
35 Alhankawi AR, Al-husseini JK, Spindler A, Baker C, Shoniwa TT, Ahmed M, Chiarelli PA, Johal MS. The Relationship between Hydrophobicity and Drug-Protein Binding in Human Serum Albumin: A Quartz Crystal Microbalance Study. Biophysica 2022;2:113-120. [DOI: 10.3390/biophysica2020012] [Reference Citation Analysis]
36 Sharifi S, Saei AA, Gharibi H, Mahmoud NN, Harkins S, Dararatana N, Lisabeth EM, Serpooshan V, Végvári Á, Moore A, Mahmoudi M. Mass Spectrometry, Structural Analysis, and Anti-Inflammatory Properties of Photo-Cross-Linked Human Albumin Hydrogels. ACS Appl Bio Mater 2022. [PMID: 35544705 DOI: 10.1021/acsabm.2c00109] [Reference Citation Analysis]
37 Khramtsov P, Kropaneva M, Bochkova M, Timganova V, Kiselkov D, Zamorina S, Rayev M. Synthesis and Application of Albumin Nanoparticles Loaded with Prussian Blue Nanozymes. Colloids and Interfaces 2022;6:29. [DOI: 10.3390/colloids6020029] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
38 Cai N, Lai AC, Liao K, Corridon PR, Graves DJ, Chan V. Recent Advances in Fluorescence Recovery after Photobleaching for Decoupling Transport and Kinetics of Biomacromolecules in Cellular Physiology. Polymers 2022;14:1913. [DOI: 10.3390/polym14091913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
39 Kunde SS, Wairkar S. Targeted delivery of albumin nanoparticles for breast cancer: A review. Colloids Surf B Biointerfaces 2022;213:112422. [PMID: 35231688 DOI: 10.1016/j.colsurfb.2022.112422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Ajnai G, Cheng C, Kan T, Lu J, Rahayu S, Chiu A, Chang J. Improving Tirapazamine (TPZ) to Target and Eradicate Hypoxia Tumors by Gold Nanoparticle Carriers. Pharmaceutics 2022;14:847. [DOI: 10.3390/pharmaceutics14040847] [Reference Citation Analysis]
41 Muntimadugu E, Silva-Abreu M, Vives G, Loeck M, Pham V, Del Moral M, Solomon M, Muro S. Comparison between Nanoparticle Encapsulation and Surface Loading for Lysosomal Enzyme Replacement Therapy. Int J Mol Sci 2022;23:4034. [PMID: 35409394 DOI: 10.3390/ijms23074034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Rajkhowa S, Pathak U, Patgiri H. Elucidating the Interaction and Stability of Withanone and Withaferin‐A with Human Serum Albumin, Lysozyme and Hemoglobin Using Computational Biophysical Modeling. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202103938] [Reference Citation Analysis]
43 Zhang Z, Yang T, Zhang J, Li W, Li S, Sun H, Liang H, Yang F. Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy. J Med Chem 2022. [PMID: 35324188 DOI: 10.1021/acs.jmedchem.1c01790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Habibi N, Mauser A, Ko Y, Lahann J. Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches. Adv Sci (Weinh) 2022;9:e2104012. [PMID: 35077010 DOI: 10.1002/advs.202104012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
45 Hatami E, Nagesh PKB, Chauhan N, Jaggi M, Chauhan SC, Yallapu MM. In Situ Nanoparticle Self-Assembly for Combination Delivery of Therapeutics to Non-Small Cell Lung Cancer. ACS Appl Bio Mater 2022. [PMID: 35179871 DOI: 10.1021/acsabm.1c01158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Teixeira S, Carvalho MA, Castanheira EMS. Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review. Biomedicines 2022;10:486. [DOI: 10.3390/biomedicines10020486] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
47 Sozer SC, Akdogan Y. Characterization of Water Solubility and Binding of Spin Labeled Drugs in the Presence of Albumin Nanoparticles and Proteins by Electron Paramagnetic Resonance Spectroscopy. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202103890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Raveendran R, Dan Xu Y, Joshi N, Stenzel MH. Progress of albumin-polymer conjugates as efficient drug carriers. Pure and Applied Chemistry 2022;0. [DOI: 10.1515/pac-2021-2006] [Reference Citation Analysis]
49 Wen X, Xu P, Shi M, Liu J, Zeng X, Zhang Y, Shi C, Li J, Guo Z, Zhang X, Khong PL, Chen X. Evans blue-modified radiolabeled fibroblast activation protein inhibitor as long-acting cancer therapeutics. Theranostics 2022;12:422-33. [PMID: 34987657 DOI: 10.7150/thno.68182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
50 Dhiman S, Kour R, Kumar G, Kaur S, Luxami V, Singh P, Kumar S. “Turn-On” monopodal and dipodal nanoprobes for serum albumins – a case of shift in selectivity towards BSA and a Z- to U-like conformational change. Mater Chem Front . [DOI: 10.1039/d2qm00699e] [Reference Citation Analysis]
51 Lima Cavalcanti ID. Chemotherapeutic Protocols for the Treatment of Gastrointestinal Tract Cancer. Chemotherapy Protocols and Infusion Sequence 2022. [DOI: 10.1007/978-3-031-10839-6_5] [Reference Citation Analysis]
52 Chen X, Cen L, Liu Q, Chu Y, Feng X, Ke Y, Zhang Z, Dai H, Huang S, Liu B, Qian X. A dual-adjuvant neoantigen nanovaccine loaded with imiquimod and magnesium enhances anti-tumor immune responses of melanoma. Biomater Sci 2022. [DOI: 10.1039/d2bm01340a] [Reference Citation Analysis]
53 Cheng Z, Huang Y, Shen Q, Zhao Y, Wang L, Yu J, Lu W. A camptothecin-based, albumin-binding prodrug enhances efficacy and safety in vivo. Eur J Med Chem 2021;226:113851. [PMID: 34547508 DOI: 10.1016/j.ejmech.2021.113851] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
54 Rabbani G, Ahn SN. Review: Roles of human serum albumin in prediction, diagnoses and treatment of COVID-19. Int J Biol Macromol 2021;193:948-55. [PMID: 34673106 DOI: 10.1016/j.ijbiomac.2021.10.095] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]
55 Geng T, Zhao L, Wu D, Zhang H, Zhao X, Jiao M, Zeng L. Bovine Serum Albumin-Encapsulated Ultrasmall Gold Nanoclusters for Photodynamic Therapy of Tumors. ACS Appl Nano Mater 2021;4:13818-25. [DOI: 10.1021/acsanm.1c03209] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
56 Yang S, Zhang W, Liu Z, Zhai Z, Hou X, Wang P, Ge G, Wang F. Lysine reactivity profiling reveals molecular insights into human serum albumin-small-molecule drug interactions. Anal Bioanal Chem 2021;413:7431-40. [PMID: 34676431 DOI: 10.1007/s00216-021-03700-1] [Reference Citation Analysis]
57 Han S, Mei L, Quach T, Porter C, Trevaskis N. Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles. Pharm Res 2021;38:1497-518. [PMID: 34463935 DOI: 10.1007/s11095-021-03093-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
58 Kashapov R, Ibragimova A, Pavlov R, Gabdrakhmanov D, Kashapova N, Burilova E, Zakharova L, Sinyashin O. Nanocarriers for Biomedicine: From Lipid Formulations to Inorganic and Hybrid Nanoparticles. Int J Mol Sci 2021;22:7055. [PMID: 34209023 DOI: 10.3390/ijms22137055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]